Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001493152-25-006574
Filing Date
2025-02-14
Accepted
2025-02-14 06:46:48
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 4907
  Complete submission text file 0001493152-25-006574.txt   6665
Mailing Address 15 CROSBY DRIVE BEDFORD MA 01730
Business Address 15 CROSBY DRIVE BEDFORD MA 01730 781-357-4000
OCULAR THERAPEUTIX, INC (Subject) CIK: 0001393434 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-88264 | Film No.: 25623094
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address ONE BOSTON PLACE SUITE 2600 BOSTON MA 02108
Business Address ONE BOSTON PLACE SUITE 2600 BOSTON MA 02108 617-904-9195
Opaleye Management Inc. (Filed by) CIK: 0001595855 (see all company filings)

EIN.: 205648796 | State of Incorp.: MA | Fiscal Year End: 1231
Type: SCHEDULE 13G/A